Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
MMPs are required for recruitment of antigen-nonspecific mononuclear cells into the liver by CTLs
Giovanni Sitia, … , Francis V. Chisari, Luca G. Guidotti
Giovanni Sitia, … , Francis V. Chisari, Luca G. Guidotti
Published April 15, 2004
Citation Information: J Clin Invest. 2004;113(8):1158-1167. https://doi.org/10.1172/JCI21087.
View: Text | PDF
Article Hepatology

MMPs are required for recruitment of antigen-nonspecific mononuclear cells into the liver by CTLs

  • Text
  • PDF
Abstract

We recently showed that antigen-nonspecific inflammatory cells are recruited into the liver when hepatitis B virus (HBV)-specific CTLs are injected into HBV transgenic mice, and that this process amplifies the severity of liver disease. We also showed that the severity of CTL-induced liver disease is ameliorated by the depletion of Gr-1+ cells (Gr-1 is an antigen highly expressed by neutrophils), which, secondarily, abolishes the intrahepatic recruitment of all antigen-nonspecific Gr-1– mononuclear cells (NK and NKT cells, T and B lymphocytes, monocytes, macrophages, dendritic cells) despite the strong induction of chemokine gene expression. Those results suggested that in addition to chemokine expression, CTL-induced functions are necessary for mononuclear cell recruitment to occur. We now report that MMPs known to be produced by Gr-1+ cells are rapidly induced in the livers of CTL-injected mice. The inhibition of MMP activity reduced the intrahepatic recruitment of antigen-nonspecific mononuclear cells and much of the attending liver disease without affecting the migration or antiviral potential of antigen-specific CTLs. The notion that the inhibition of MMP activity is associated with maintenance of antiviral effects but diminished tissue damage may be significant for the development of immunotherapeutic approaches for the treatment of chronic HBV infection.

Authors

Giovanni Sitia, Masanori Isogawa, Matteo Iannacone, Iain L. Campbell, Francis V. Chisari, Luca G. Guidotti

×

Figure 3

Options: View larger image (or click on image) Download as PowerPoint
Enhanced expression of TIMP-1 reduces the recruitment of IHLs and amelio...
Enhanced expression of TIMP-1 reduces the recruitment of IHLs and ameliorates the severity of liver disease. Two groups of age- and serum HBeAg-matched female transgenic mice from lineage 1.3.32 (six mice per group) were hydrodynamically injected (hydr. inj.) with either pcDNA3.1-TIMP-1 (TIMP-1 + CTL, black bars) or an empty vector (Vector + CTL, white bars), and 2 days later they received 1 × 107 HBsAg-specific CTLs. Mice were bled, sacrificed, and perfused; the livers were harvested on day 1 after CTL transfer (day 3 after hydrodynamic injection). Serum TIMP-1 ELISA (left panel) measured 1 day after hydrodynamic injection and total IHLs (middle panel) or sALT (right panel) measured 1 day after CTL injection were also compared with two additional groups of transgenic littermates (six mice per group) that were hydrodynamically injected with pcDNA3.1-TIMP-1 (TIMP-1, dark gray bars) or saline (NaCl, light gray bars).

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts